home.aspx
 
EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Biotest AG

Biotest is a company specialising in innovative hematology and immunology products with the holistic approach of a global pharmaceutical.

RELATED NEWS


Fulminate sepsis is a dangerous condition, usually caused by a bacterial infection. The runaway behavior of the immune system in sepsis is still poorly understood. The trick is to diagnose it early and to use antibiotics to fight it off. These days it can take up to three days to diagnose sepsis, usually via a blood culture, which is one of the primary reasons that it is one of the main causes of death inside of hospitals. Researchers at the University of Strathclyde in Scotland have developed a...

READ MORE

Jake Layzell, 25 of Newland Street in Witham, pleaded guilty to possession with intent to supply cocaine and possession of cannabis at Basildon Crown Court on Friday, April 26. He had been stopped by officers a month previously on Monday, March 4 when travelling on the A130 in his van near South Woodham Ferrers. Police officers, aided by a specialist detection dog trained to detect cash, firearms and drugs discovered £2,000 cash in Mr Layzell's jacket pocket while indicating the presen...

READ MORE

Nova Laboratories has announced details of its “revolutionary” new liquid formation of hydroxycarbamide for sickle cell disease. The product in question, Xromi (hydroxycarbamide), was granted a license by the European Medicines Agency (EMA) in July 2019, and represents a significant evolution of solid dosage forms of the drug that have been used in the treatment of sickle cell disease since the 1990s. The new liquid formation makes administering the drug to children as young as two-y...

READ MORE

The National Institute for Health and Care Excellence has issued a final green light securing routine NHS funding for Roche’s Perjeta in patients with a certain type of breast cancer. The guidelines follow a confidential commercial agreement for Perjeta (pertuzumab) agreed between NHS England and the drugmaker late last year, paving the way for its move from the Cancer Drugs Fund (CDF) to the NHS’ routine commissioning stream, when used to treat advanced HER2-positive breast cancer. ...

READ MORE

Powered leg prostheses can give amputees the ability to walk for long periods of time and to do so briskly. The reality is that these devices are pretty clunky and programming them to operate smoothly to produce a natural gait takes hours, and the results are rarely perfect. Scientists at North Carolina State University, the University of North Carolina, and Arizona State University have now developed an automated tuning system that relies purely on a technique called reinforcement learning to d...

READ MORE

In a major boon for UK diagnostics group Owlstone Medical, GlaxoSmithKline is incorporating the firm’s Breath Biopsy platform into the clinical development programme for its novel, experimental respiratory drug danirixin....

READ MORE

EVENTS

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...